Prostate Cancer Trial, Recruiting NCT06579417 Sponsor: University of California, San Diego Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT06579417
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been referred for a specialised prostate MRI scan because their doctor suspects prostate cancer
  • People whose MRI scan will be carried out using a specific standardised scanning method called the ART-Pro acquisition protocol

Who may not be able to join:

  • People who are currently in prison or otherwise incarcerated
  • People who have previously been diagnosed with prostate cancer
  • People who currently have another type of cancer (not prostate cancer) in areas of the body close to the prostate
  • People who have had previous surgery on the prostate
  • People who have a history of a hip implant
  • People who have metal implants or other implanted devices in their body, or any other factor that would require changes to the usual MRI scanning process (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tyler Seibert, MD, PhD, University of California, San Diego

Phone: 858-246-2180

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 December 2023
Est. completion
1 July 2026

Where this trial is recruiting

🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Proportion of patients diagnosed with a grade group ≥2 prostate cancer on biopsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov